Bank Of America Corp Genenta Science S.P.A. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
Shares
3 transactions
Others Institutions Holding GNTA
# of Institutions
5Shares Held
360KCall Options Held
0Put Options Held
0-
Al Ti Global, Inc. New York, NY200KShares$789,1340.02% of portfolio
-
Allianz Se Munich, 2M103KShares$406,8050.01% of portfolio
-
Algebris (Uk) LTD London, X045KShares$177,3000.06% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il11.2KShares$43,9970.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $71.8M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...